Diabetes care product company ARKRAY USA Inc reported on Monday the launch of newest blood glucose monitoring system (BGMS) in the US, the GLUCOCARD Shine XL.
According to the company, the GLUCOCARD Shine XL blood glucose monitoring system is now available for order in the US.
Highly accurate with a large LED screen intended to facilitate quick and easy viewing of blood glucose test results, the GLUCOCARD Shine XL BGMS offers an ergonomically designed meter that provides a secure grip during testing as well as uses the same test strips as the prior GLUCOCARD Shine, which has been proven to provide highly accurate test results in an easy to use form.
ARKRAY USA Inc, which is a division of ARKRAY headquartered in Kyoto, Japan, currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the US.
Novo Nordisk to acquire Akero Therapeutics in USD5.2bn deal to strengthen MASH pipeline
DarioHealth and OneStep partner to integrate fall risk technology into digital health platform
Renalytix submits CE Mark application for kidneyIntelX.dkd in Europe
Ocular Therapeutix prices USD475m common stock offering
Early, Evidence-Led Cardiovascular Care Strengthened in High-Risk MENA Regions
Nanomi BV to acquire ophthalmology specialist VISUfarma BV
AstraZeneca launches online platform to expand patient access to medications
Avant Technologies enters joint venture to advance stem cell-based diabetes treatments
Innovent and Ollin report progress in development of OLN324 (IBI324)
Alteogen secures European Commission approval for aflibercept biosimilar EYLUXVI
Eli Lilly and Company's orforglipron outperforms oral semaglutide in Phase 3 ACHIEVE-3 trial
Ascletis presents ASC30 study results at EASD Annual Meeting
Kodiak reports positive APEX data for KSI-101 in macular edema secondary to inflammation
Renalytix signs collaboration agreement with Tempus AI to expand KidneyIntelX.dkd access